Almeida, L.F.C. de et al. 2026. CDK4/6 inhibitor plus endocrine therapy after progression on CDK4/6 inhibition in HR+/HER2- advanced breast cancer: a systematic review and meta-analysis (ReIGNITE study). Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1011.